Division of Oral and Maxillofacial Surgery, Department of Stomatology, Taichung Veterans General Hospital, Taichung, 407204, Taiwan.
School of Dentistry, College of Oral Medicine, Chung Shan Medical University, Taichung, 402367, Taiwan.
BMC Cancer. 2020 Apr 15;20(1):310. doi: 10.1186/s12885-020-06839-9.
Cancer development is mediated by oxidative stress and inflammation, which may correlate with metabolic disorders. The aim of this study was to evaluate antioxidant vitamins status and metabolic parameters in patients with oral cancer according to tumor-node-metastasis (TNM) stages.
A total of 194 patients with oral cancer were enrolled in this study. The patients were stratified for four groups according to cancer stages and that the statistics are comparisons across these groups. The levels of antioxidant vitamins (ubiquinone, β-carotene, vitamin A and E), metabolic parameters, oxidative stress, antioxidant enzymes activity, and inflammatory markers were measured.
More than half of the subjects had high blood pressure, central obesity, hyperglycemia, and hyperlipidemia regardless of TNM stage. With regard to antioxidant vitamins status, 46 and 94% of patients had β-carotene and ubiquinone deficiency, respectively. Patients in T3 and T4 stages had significantly lower antioxidant enzyme (catalase, p = 0.03) activity and higher inflammatory markers levels (high sensitivity C-reactive protein and interleukin-6, p < 0.01) than patients in the other stages. In addition, the level of β-carotene was negatively associated with waist circumference, and ubiquinone was positively associated with the level of high-density lipoprotein cholesterol (p < 0.05). Higher β-carotene and ubiquinone levels were negatively associated with hypertriglyceridemia and the risk of metabolic syndrome (p < 0.05).
A high proportion of patients with oral cancer had ubiquinone or β-carotene deficiency and metabolic disorders. The level of ubiquinone or β-carotene was negatively associated with the risk of central obesity, hypertriglyceridemia, and metabolic syndrome. Since patients with oral cancer suffer from high oxidative stress and inflammation (particularly in the T3 and T4 stages), supplementation with antioxidant vitamins such as ubiquinone or β-carotene could be preferentially applied.
癌症的发展是由氧化应激和炎症介导的,这可能与代谢紊乱有关。本研究旨在根据肿瘤-淋巴结-转移(TNM)分期评估口腔癌患者的抗氧化维生素状态和代谢参数。
本研究共纳入 194 例口腔癌患者。根据癌症分期将患者分为 4 组,对这些组进行统计比较。测量抗氧化维生素(泛醌、β-胡萝卜素、维生素 A 和 E)、代谢参数、氧化应激、抗氧化酶活性和炎症标志物的水平。
超过一半的患者无论 TNM 分期如何,均有高血压、中心性肥胖、高血糖和高血脂。就抗氧化维生素状态而言,分别有 46%和 94%的患者β-胡萝卜素和泛醌缺乏。T3 和 T4 期的患者抗氧化酶(过氧化氢酶,p=0.03)活性明显较低,炎症标志物水平(高敏 C 反应蛋白和白细胞介素 6,p<0.01)较高。此外,β-胡萝卜素水平与腰围呈负相关,而泛醌与高密度脂蛋白胆固醇水平呈正相关(p<0.05)。较高的β-胡萝卜素和泛醌水平与高三酰甘油血症和代谢综合征的风险呈负相关(p<0.05)。
口腔癌患者有相当一部分存在泛醌或β-胡萝卜素缺乏和代谢紊乱。泛醌或β-胡萝卜素水平与中心性肥胖、高三酰甘油血症和代谢综合征的风险呈负相关。由于口腔癌患者存在高氧化应激和炎症(尤其是在 T3 和 T4 期),因此可以优先补充抗氧化维生素,如泛醌或β-胡萝卜素。